Therapeutic Strategy Details
| Strategy ID: | S13 |
| Strategy: | genetic therapy |
| Other Terms: | Genetic therapy; regenerative therapies; genetic depletion of LCN2; regulates genes related to iron metabolism; Immunotherapy; Genetic therapy |
| Related Targets: | HIF |
| Related Drugs: | Adriamycin; aspirin; penicillin G; cisplatin; HDAC-inhibitors; HDAC4-inhibitors; HDAC4 siRNA; Streptozotocin; anti-LCN2 antibodies; daprodustat; darbepoetin alfa; erythropoiesis-stimulating agents; miR-10a-3p agomir; miR-10a-3p antagomir; REG3A low expression vector; Mdivi1; antagomir-148a |
| Mechanism: | |
| Reference (PMIDs): | 31097789; 32166969; 32453574; 32622525; 32646856; 32723804; 32853927; 32994406; 33013825 |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|
| Candidate ID | Source ID | Source Type | Compound Type | Candidate Name | Inclusion Criteria |
|---|
| Article ID | PMID | Source | Title |
|---|